Full-Time

Legal Specialist

Intellectual Property

Posted on 3/18/2025

Becton Dickinson

Becton Dickinson

10,001+ employees

Global medical technology and diagnostics provider

Compensation Overview

$73.3k - $121kAnnually

Mid

Salt Lake City, UT, USA + 2 more

More locations: Midland Park, NJ, USA | San Diego, CA, USA

Minimum of 4 days in-office presence per week required.

Category
Intellectual Property (IP)
Legal & Compliance
Required Skills
Word/Pages/Docs
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides
Requirements
  • Bachelor’s degree or equivalent experience required
  • 3 years of relevant IP work experience in a law firm or in-house required
  • Proficiency in Microsoft Office Suite including Word, Excel, PowerPoint and Outlook
  • Excellent attention to detail and accuracy
  • Strong organization skills
  • Ability to communicate clearly and professionally both verbally and in writing
  • Self-motivated and resourceful
  • Ability to establish and maintain effective working relationships with others
  • Strong interpersonal skills and ability to interact with all levels within the company
Responsibilities
  • Assisting patent attorneys with prosecution of patent applications before the United States Patent & Trademark Office (USPTO) and foreign patent offices
  • Drafting correspondence with foreign patent offices and counsel related to foreign prosecution matters
  • Maintenance of internal databases
  • Creating spreadsheets and preparing charts for tracking purposes
  • Reviewing documents for quality assurance
  • Providing general administrative support to Patent Department staff
  • Communicating effectively with other departments and outside counsel
  • Working on special projects as assigned.
Desired Qualifications
  • Paralegal Certification preferred but not required

Becton Dickinson (BD) is a global medical technology company that enhances health through improved medical discovery, diagnostics, and care delivery. It serves hospitals, laboratories, and healthcare providers worldwide. BD operates in three main areas: BD Medical, which focuses on solutions for medication management and delivery; BD Life Sciences, which provides products for the safe collection and transport of diagnostic specimens; and BD Interventional, which offers devices for minimally invasive surgeries. BD generates revenue by selling medical devices, laboratory equipment, and diagnostic products. The company stands out from competitors by emphasizing innovation, quality, and customer service, with the goal of improving patient outcomes, reducing healthcare costs, and increasing safety and efficiency in healthcare environments.

Company Size

10,001+

Company Stage

IPO

Headquarters

Franklin Lakes, New Jersey

Founded

1961

Simplify Jobs

Simplify's Take

What believers are saying

  • BD's focus on digital health aligns with telemedicine and remote monitoring trends.
  • BD's investment in syringe manufacturing supports pandemic preparedness.
  • BD's acquisition of Tissuemed enhances its minimally invasive surgical solutions.

What critics are saying

  • Increased competition from companies like Abbott and Roche in digital health.
  • Potential regulatory challenges with new acquisitions like MedKeeper and Scanwell Health.
  • Supply chain vulnerabilities in sourcing raw materials for syringe manufacturing.

What makes Becton Dickinson unique

  • BD's acquisition of MedKeeper enhances its cloud-based pharmacy management capabilities.
  • BD's investment in syringe manufacturing aligns with global vaccination trends.
  • BD's acquisition of Cytognos expands its post-treatment monitoring capabilities.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Tuition Reimbursement

Company News

Slater Sentinel
Jan 4th, 2024
Affinity Wealth Management LLC Invests $2.18 Million in Becton, Dickinson and Company (NYSE:BDX)

Affinity Wealth Management LLC purchased a new stake in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 8,443 shares of the medical instruments supplier’s stock, valued at approximately $2,183,000. Other […]

PR Newswire
Jul 28th, 2022
BD Acquires MedKeeper to Offer Cloud-based, Connected Pharmacy Software

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has acquired MedKeeper, a...

ROI-NJ
Jul 28th, 2022
Bd Acquires Medkeeper To Offer Cloud-Based, Connected Pharmacy Software

BD on Thursday said it acquired MedKeeper, a provider of modern, cloud-based pharmacy management applications. The acquisition adds to the Franklin Lakes-based company’s recent growth in high-technology pharmacy solutions and further accelerates its commitment to smart, connected care

PR Newswire
Feb 9th, 2022
Day Zero Diagnostics Announces Completion of $21M Financing

/PRNewswire/ -- Day Zero Diagnostics, Inc., an infectious disease diagnostics company harnessing the power of whole-genome sequencing and machine learning to...

PR Newswire
Feb 1st, 2022
BD Expands from Cancer Discovery and Diagnosis into Post-Treatment Monitoring with Acquisition of Cytognos from Vitro S.A.

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition...